UniPharma Co., Ltd. (6621.TWO)

TWD 13.85

(-0.72%)

Operating Income Summary of UniPharma Co., Ltd.

  • UniPharma Co., Ltd.'s latest annual operating income in 2023 was -27.3 Million TWD , down -211.95% from previous year.
  • UniPharma Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -7 Million TWD , down 0.0% from previous quarter.
  • UniPharma Co., Ltd. reported an annual operating income of -6.98 Million TWD in 2022, up 90.6% from previous year.
  • UniPharma Co., Ltd. reported an annual operating income of -74.3 Million TWD in 2021, down -34.59% from previous year.
  • UniPharma Co., Ltd. reported a quarterly operating income of -7 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • UniPharma Co., Ltd. reported a quarterly operating income of -8.98 Million TWD for 2023 Q3, down -92.63% from previous quarter.

Annual Operating Income Chart of UniPharma Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of UniPharma Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -27.3 Million TWD -211.95%
2022 -6.98 Million TWD 90.6%
2021 -74.3 Million TWD -34.59%
2020 -55.21 Million TWD -98.58%
2019 -27.8 Million TWD 0.0%

Peer Operating Income Comparison of UniPharma Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 130.779%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 117.781%
Easywell Biomedicals, Inc. -162.73 Million TWD 83.221%
TTY Biopharm Company Limited 1.37 Billion TWD 101.99%
Synmosa Biopharma Corporation 614.74 Million TWD 104.442%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 132.293%
Center Laboratories, Inc. -79.26 Million TWD 65.552%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD 233.612%
Orient Pharma Co., Ltd. 27.75 Million TWD 198.386%
InnoPharmax Inc. -64.83 Million TWD 57.888%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 125.864%
Excelsior Biopharma Inc. -81.12 Million TWD 66.343%
DV Biomed Co., Ltd. 173.54 Million TWD 115.733%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 97.29%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 103.924%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD 151.371%
Alar Pharmaceuticals Inc. 385.52 Million TWD 107.083%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 113.924%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 40.239%
Bioray Biotech Co., Ltd -19.33 Million TWD -41.25%
TSH Biopharm Corporation Limited 63.63 Million TWD 142.912%